You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cladribine

Showing 1 - 25 of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, MDS, Acute Myeloid Leukemia Trial in Houston (Cladribine)

Not yet recruiting
  • Leukemia
  • +2 more
  • Cladribine
  • Houston, Texas
    M D Anderson Cancer Center
Aug 28, 2023

Acute Myeloid Leukemia Trial (MCBC regimen, Bu/Cy regimen)

Not yet recruiting
  • Acute Myeloid Leukemia
  • MCBC regimen
  • Bu/Cy regimen
  • (no location specified)
Nov 13, 2023

Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)

Recruiting
  • Acute Myeloid Leukemia, Adult
  • cladribine + homoharringtonine + cytarabine
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023

Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level

Not yet recruiting
  • Relapsed Adult AML
  • Refractory AML
  • Navitoclax Dose Level -1
  • +10 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Porto Alegre (Cladribine 10 mg oral tablet)

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Cladribine 10 mg oral tablet
  • Porto Alegre, RS, Brazil
    Pontifical Catholic University of Rio Grande do Sul
Jun 5, 2023

Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride

Recruiting
  • Multiple Sclerosis, Secondary Progressive
  • Multiple Sclerosis
  • Cladribine Subcutaneous Injection
  • 0.9% Chloride Injection Sodium
  • Warsaw, Mazowieckie, Poland
    Institute of Psychiatry and Neurology
Jul 26, 2023

Acute Myeloid Leukemia, MDS Trial (Cladribine, Cytarabine, Decitabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Cladribine
  • +4 more
  • (no location specified)
Mar 1, 2023

Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial in Saint Louis (Cladribine)

Recruiting
  • Multiple Sclerosis
  • Multiple Sclerosis, Relapsing-Remitting
  • Cladribine
  • Saint Louis, Missouri
  • +4 more
Jan 4, 2023

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (Cladribine, Fludarabine)

Recruiting
  • Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 12, 2022

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • cladribine, cytarabine,venetoclax
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 22, 2022

Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Gilteritinib 40 MG Oral Tablet
  • +4 more
  • Lexington, Kentucky
    University of Kentucky
Oct 27, 2022

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Cladribine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Myeloid Leukemia Trial in Nanjing (Chidamide, Cladribine)

Recruiting
  • Acute Myeloid Leukemia
  • Nanjing, Jiangsu, China
    Department of Hematology, Zhongda Hospital Southeast University,
Apr 23, 2022

Microglial Activation in the CNS

Active, not recruiting
  • Multiple Sclerosis
  • Imaging
  • Turku, Finland Proper, Finland
    Turku PET Centre
May 31, 2022

Predictors in Clinical Practice (CLODINA)

Not yet recruiting
  • Multiple Sclerosis
  • Bruxelles, Belgium
  • +29 more
Mar 22, 2023

Untreated Adult Acute Myeloid Leukemia Trial in Houston (Cladribine, Guadecitabine, Idarubicin)

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

Cladribine Therapy After Anti CD20 Therapy

Active, not recruiting
  • Multiple Sclerosis
  • Cladribine Oral Tablet
  • +2 more
  • Lugano, Ticino, Switzerland
    Neurocenter of Southern Switzerland, Ospedale Regionale di Lugan
Mar 22, 2022

Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Cladribine
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

Recruiting
  • Acute Biphenotypic Leukemia
  • +13 more
  • Cladribine
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • Cladribine
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Czech Pharmaco-epidemiological Study on Disease Modifying Drugs

Completed
  • Multiple Sclerosis
  • interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
  • Prague, Czechia
    IMPULS Endowment Fund
Mar 7, 2023

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023